Urticarial vasculitis - Cudurka Vaskulitis Ee 'Urticarial'
☆ Natiijooyinka Stiftung Warentest ee 2022 ee ka yimid Jarmalka, ku qanacsanaanta macaamilka ee ModelDerm ayaa waxyar uun ka hooseysay la-talinta telemedicine-ka ee lacagta lagu bixiyo.
References
Urticarial vasculitis waa xaalad naadir ah oo lagu asteeyay xanuuno raagay ama soo noqnoqda. Iyadoo astaamihiisa maqaarku ay u ekaan karaan finan dabadheeraad ah, waa kuwo gaar ah sababtoo ah finan-cuncunku waxay ku dheggan yihiin ugu yaraan 24 saacadood waxayna keeni karaan dhibco madow ka dib markay libdhaan. In kasta oo inta badan aan la garanayn sababta, mararka qaarkood waxaa kicin kara daawooyinka qaarkood, caabuqyada, cudurrada difaaca jirka, cilladaha dhiigga, ama kansarrada. Daraasadaha qaar ayaa xitaa ku xiray COVID-19 iyo hargabka H1N1. Waxay kaloo saamayn kartaa qaybaha kale ee jidhka sida murqaha, kelyaha, sambabada, caloosha, iyo indhaha. In kasta oo nooc ka mid ah baaritaanka unuggu uu xaqiijin karo ogaanshaha, mar walba lama huraan. Daawaynta caadi ahaan waxay ku bilaabataa antibiyootik, dapsone, colchicine, ama hydroxychloroquine xaaladaha fudud. Kiisaska aadka u daran, daawooyinka xakameynaya habka difaaca jirka sida methotrexate ama corticosteroids ayaa laga yaabaa in loo baahdo. Dhawaan, daawaynta bayoolojiga (rituximab, omalizumab, interleukin-1 inhibitors) waxay muujisay ballanqaad kiisaska adag.
Urticarial vasculitis is a rare clinicopathologic entity that is characterized by chronic or recurrent episodes of urticarial lesions. Skin findings of this disease can be difficult to distinguish visually from those of chronic idiopathic urticaria but are unique in that individual lesions persist for ≥24 hours and can leave behind dusky hyperpigmentation. This disease is most often idiopathic but has been linked to certain drugs, infections, autoimmune connective disease, myelodysplastic disorders, and malignancies. More recently, some authors have reported associations between urticarial vasculitis and COVID-19, as well as influenza A/H1N1 infection. Urticarial vasculitis can extend systemically as well, most often affecting the musculoskeletal, renal, pulmonary, gastrointestinal, and ocular systems. Features of leukocytoclastic vasculitis seen on histopathologic examination are diagnostic of this disease, but not always seen. In practice, antibiotics, dapsone, colchicine, and hydroxychloroquine are popular first-line therapies, especially for mild cutaneous disease. In more severe cases, immunosuppressives, including methotrexate, mycophenolate mofetil, azathioprine, and cyclosporine, as well as corticosteroids, may be necessary for control. More recently, select biologic therapies, including rituximab, omalizumab, and interleukin-1 inhibitors have shown promise for the treatment of recalcitrant or refractory cases.
Urticarial vasculitis is a rare clinicopathologic entity that is characterized by chronic or recurrent episodes of urticarial lesions. Skin findings of this disease can be difficult to distinguish visually from those of chronic idiopathic urticaria but are unique in that individual lesions persist for ≥24 hours and can leave behind dusky hyperpigmentation. This disease is most often idiopathic but has been linked to certain drugs, infections, autoimmune connective disease, myelodysplastic disorders, and malignancies. More recently, some authors have reported associations between urticarial vasculitis and COVID-19, as well as influenza A/H1N1 infection. Urticarial vasculitis can extend systemically as well, most often affecting the musculoskeletal, renal, pulmonary, gastrointestinal, and ocular systems. Features of leukocytoclastic vasculitis seen on histopathologic examination are diagnostic of this disease, but not always seen. In practice, antibiotics, dapsone, colchicine, and hydroxychloroquine are popular first-line therapies, especially for mild cutaneous disease. In more severe cases, immunosuppressives, including methotrexate, mycophenolate mofetil, azathioprine, and cyclosporine, as well as corticosteroids, may be necessary for control. More recently, select biologic therapies, including rituximab, omalizumab, and interleukin-1 inhibitors have shown promise for the treatment of recalcitrant or refractory cases.
Nin 35 jir ah ayaa soo galay isagoo leh taariikh 15 maalmood ah oo casaan dhalaalaya ah, nabaro xanuun badan oo ka soo baxay labada cajar iyo lugaha, oo ay weheliyaan xanuun kala goysyo ah. Waxa uu ku dhacay caabuq ku dhaca kaadi mareenka muddo toddobaad ah ka hor inta aanay finanku soo bixin. Maqaarkiisu waxa ka muuqday dhawr jilicsan, giraan-qaabeeya, qayb ahaan bannaan, tabeello cas oo ku yaalla labada dhinac ee bowdyaha iyo lugaha. Waxa la siiyay prednisolone afka laga qaato (40mg/maalintii) toddobaad oo ay weheliso antihistamine-ka aan hurdo lahayn (fexofenadine) . Usbuuc gudihiis, dhammaan finanka ayaa si buuxda u baaba'ay. Ma jirin wax firiiric ah oo soo baxay 6da bilood ee soo socota ee baaritaanka caadiga ah.
A 35-year-old man came in with a 15-day history of bright red, painful rashes on both thighs and legs, along with joint pain. He had a urinary tract infection for a week before the rash appeared. His skin showed several tender, ring-shaped, partially blanchable, red plaques on both sides of his thighs and legs. He was given oral prednisolone (40mg/day) for a week along with a non-drowsy antihistamine (fexofenadine). Within a week, all the rashes disappeared completely. There were no more rashes during the next 6 months of regular check-ups.
A 35-year-old man came in with a 15-day history of bright red, painful rashes on both thighs and legs, along with joint pain. He had a urinary tract infection for a week before the rash appeared. His skin showed several tender, ring-shaped, partially blanchable, red plaques on both sides of his thighs and legs. He was given oral prednisolone (40mg/day) for a week along with a non-drowsy antihistamine (fexofenadine). Within a week, all the rashes disappeared completely. There were no more rashes during the next 6 months of regular check-ups.
○ Daawaynta - Daawooyinka OTC
Haddii aad leedahay qandho (kulka jidhka oo kordha), waxaanu kugula talinaynaa inaad sida ugu dhakhsaha badan u raadsato daryeel caafimaad.
Daawada looga shakisan yahay waa in la joojiyo. (tusaale, antibiyootiga, dawooyinka caabuqa ee aan steroid ahayn)
Dawooyinka afka laga qaato sida cetirizine ama loratadine ee cuncunka.
#Cetirizine [Zytec]
#LevoCetirizine [Xyzal]
#Loratadine [Claritin]
Boomaatada steroid-ka ee OTC waxay noqon kartaa mid aan waxtar u lahayn awoodda hoose. Wuxuu u baahan yahay in la codsado in ka badan toddobaad si loo arko horumar.
#Hydrocortisone ointment